254 abstracts found.



Results filter

Management of adverse events in patients with HER2+ metastatic breast cancer treated with tucatinib, trastuzumab, and capecitabine (HER2CLIMB)

Year:

Session type:

Alicia Okines1, Elisavet Paplomata2, Tanya Wahl2, Gail Wright2, Stephanie Sutherland3, Erik Jakobsen2, Frances Valdes-Albini2, Arlene Chan2, Amy Clark4, Alison Conlin2, Maryam Lustberg2, Jennifer Specht2, Timothy Pluard2, Xiaofu Zhu2, Ian Krop5, Karen Gelmon6, Dennis Slamon2, Jorge Ramos2, Wentao Feng2, Erika Hamilton2
1Royal Marsden NHS Foundation Trust, 2Other, 3Mount Vernon Cancer Centre, 4University of Pennsylvania, 5Dana-Farber Cancer Institute, 6BC Cancer Agency

Efficacy and safety of avelumab + axitinib (A+Ax) vs sunitinib (S) in elderly patients with advanced renal cell carcinoma (aRCC): extended follow-up results from JAVELIN Renal 101

Year:

Session type:

Yoshihiko Tomita1, Anand Sharma2, Robert Motzer3, Toni Choueiri1, Brian Rini4, Hideaki Miyake1, Hirotsugu Uemura1, Laurence Albiges1, Yosuke Fujii1, Yoshiko Umeyama1, Jing Wang5, Mariangela Mariani1, Manuela Schmidinger1
1Other, 2Mount Vernon Cancer Centre, 3Memorial Sloan-Kettering Cancer Center, 4Vanderbilt-Ingram Cancer Center, 5Pfizer

Venous thromboembolism (VTE) in pancreatic cancer patients – single centre experience

Year:

Session type:

Ankit Rao1, Jing Hoay1, Tahir Shafiq1, Syed Karim1, Sarah Widdowson2, Junaid Mobeen2, Arvind Arora2
1Nottingham City Hospital, 2Nottingham University Hospitals NHS Trust

Safety and efficacy of lenvatinib as first-line systemic therapy for advanced hepatocellular carcinoma – a real-world single-centre retrospective analysis

Year:

Session type:

Onyinyechi Duru1, Avinash Segaran2, Ankit Rao2, Junaid Mobeen2, Sarah Widdowson2, Arvind Arora2
1Nottingham City Hospital, 2Nottingham University Hospitals NHS Trust